Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-10

Clinical Trial Update: Genetic Architecture of Natriuretic Peptides and Blood Pressure Response [NA]

View source ↗

Summary

A clinical trial update studying how genetic variation in natriuretic peptides influences blood pressure response. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Hypertension (HTN), Cardiometabolic Diseases | NA | Status: NOT_YET_RECRUITING